New ways for Medicom after the storm
There are those who have suffered during the pandemic. And there are the others… The Montreal company Medicom belongs to this second group.
• Also read: Medicom sets up a factory in Saint-Eustache
The Pointe-Claire-based manufacturer and distributor of infection prevention products used this turbulent time to experience the strongest growth spurt in its history.
Before the outbreak of Covid-19, the company had four factories. Six months later she already had ten! Ten factories, with three more to come by the end of next year…
High V speed
“We’ve had our feet and pedals on the ground since the pandemic began, the new president illustrates. Our growth has been absolutely phenomenal. »
In this context, which could easily be likened to the aftermath of a storm, Guillaume Laverdure took over the reins of the company, which until then had been managed by its founder Ronald Reuben.
Guillaume Laverdure
Medicom Managing Director
The latter had founded Medicom at the end of the 1980s – in the middle of the AIDS crisis – in order to meet the then urgent demand for gloves for medical staff.
Thirty years later, another urgent need – this time surgical masks and N95 – naturally allowed the company to double its activity, its teams and its turnover. Happily, his income today would exceed $1.5 billion.
A new reality
According to the new boss, such a company must take note of its new reality after “such a rapid upheaval” in order to be able to project itself better into the future.
For the latter, a company like Medicom, now with 2,000 employees in a dozen offices in as many countries, has to adapt its procedures. A change in organizational structure was required; a new global leadership has recently emerged.
Today, the Montreal company employs around 350 people, 200 more than before the pandemic. A significant part of this growth is due to the construction of a new mask factory in the Saint-Laurent district amid the pandemic.
manufacturing autonomy
On-site, the former 60,000 square foot warehouse houses 23 production lines. Almost 1.5 million surgical, pediatric and N95 masks are manufactured there every day. And since opening in July 2020, more than 525 million masks have been produced.
The example of such factories is in line with the recent desire of governments, but also of Medicom’s new CEO, to better control their fate and thus better manage their supply chain.
“Thanks to our long-standing relationships with our suppliers, we have never lacked for anything. But it was often tense,” admits Mr. Laverdure, referring to the outbidding movement that masks and sanitizers in particular were subjected to at the height of the pandemic.
The announcement this spring of the construction of a new $120 million nitrile glove factory in London, Ontario is a direct result of this renewed desire for manufacturing autonomy. The Ontario government is thus securing a privileged supply of 500 million gloves per year.
The same logic applies to the construction of a new $40 million production facility in Saint-Eustache for filter materials used in the composition of surgical masks and N95.
Of the G7 countries, only Canada does not have such a facility, explains Mr Laverdure, who believes this awareness by governments will benefit everyone.
MEDICOM COMING SOON
► Foundation, endowment : 1988
► Shareholders: Ronald Reuben, Founder, and Morris Goodman, Founder of Pharmascience.
► The headquarters : Pointe Claire, Quebec
► Number of employees : 2000, including 350 in Quebec
► His main trademarks: Medicom, Ritmed, Ocean Pacific, Hedy, Kolmi, Hopen
► Presence around the world: Canada, Australia, USA, France, China, South Korea, Malaysia, Japan, Taiwan, Ukraine, Netherlands.